Join Us for the Naming Ceremony of the Children’s Cancer Fund Research Laboratory
Since 1993, Children’s Cancer Fund has proudly funded pediatric cancer and blood disease research at New York Medical College. We are excited to share a milestone moment in this long-standing partnership. New York Medical College will formally naming the three research laboratories we support as the Children’s Cancer Fund Research Laboratory—a meaningful recognition of more than three decades of commitment to advancing lifesaving research.
The Children's Cancer Fund Educational Scholarship
The Children’s Cancer Fund New York Scholarship is a one-time educational award designed to support current or former patients treated for childhood cancer or blood diseases — or their siblings — as they pursue post-secondary education or vocational training in the United States
May Gala Save the Date
Friday, May 1, 2026
The View on the Hudson
6:00pm
More Details to Follow
The Children's Cancer Fund is a nonprofit committed to supporting the fight against Pediatric Cancer and Blood Diseases.
By supporting the clinical and research programs at Maria Fareri Children's Hospital and New York Medical College, we impact their ability to provide state of the art, quality care for children and adolescents right here in our Westchester community.
On the Front Lines of Hope: Dr. Mitchell Cairo’s Mission to Cure Childhood Cancer
Even on the most taxing days, Dr. Cairo draws resolve from looking back on the strides made in his field. “To put it in perspective, when I started practicing in the early 1980s, only 20 percent of children with cancer survived,” says Dr. Cairo. “For every five patients I diagnosed, I attended four funerals. Today, the cure rate is rapidly approaching 85 percent. We have had a great renaissance over the last 50 years, and we are on the brink of developing therapy that’s even more well-tolerated.”
The Helping Osteosarcoma Patients Everywhere (HOPE) Super Grant
A $1.5 million research project which began on October 1, 2023, is led by Dr. Mitchell Cairo at New York Medical College. The goal of the grant is to develop novel combinatorial immunotherapy that will significantly increase the overall survival in children and adolescents with relapsed osteosarcoma.
Courageous Chronicles: Patient Stories
Uplifting Stories of Resilience & Journeys from the Lives of Our Remarkable Patients
Join Our Newsletter
Sign up to stay connected, learn about upcoming events & more ways to contribute.